MR Biomarkers of Inflammation in Knee Osteoarthritis
膝骨关节炎炎症的 MR 生物标志物
基本信息
- 批准号:10476943
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-10-01 至 2026-09-30
- 项目状态:未结题
- 来源:
- 关键词:15qAcuteAddressAffectAnimal ModelBiochemicalBiological MarkersBlood VesselsBone MarrowCadaverCaringCartilageCellsCellularityClinicalCumulative Trauma DisordersDataDegenerative polyarthritisDetectionDiffusionDiseaseElementsEvaluationExhibitsFatty AcidsFatty acid glycerol estersFibrosisFundingGoalsHistologicHyperplasiaImageInfiltrationInflammagingInflammationInflammatoryInstitutionInterventionIntravenousJointsKneeKnee OsteoarthritisLengthLiteratureMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMapsMarrowMeasuresMediatingMeniscus structure of jointMorphologyMultivariate AnalysisMusNatural ImmunityOutcomePainPathway interactionsPatientsPeripheral Vascular DiseasesProcessPropertyProtocols documentationProtonsQuantitative EvaluationsResolutionRestriction Spectrum ImagingRiskRoleSaturated Fatty AcidsScanningStandardizationStatistical ModelsSynovial FluidSynovial MembraneSynovitisTechniquesTimeTissue DonorsTissuesTranslatingTraumatic ArthropathyVeteransVisitWaterWorkbonechromosome 5q losschronic musculoskeletal painclinical translationcohortdensitydiffusion weightedeconomic impacteffusionfollow-upfunctional improvementjoint inflammationjoint injuryknee replacement arthroplastyloss of functionmagnetic resonance imaging biomarkermilitary servicemouse modelnovelosteoarthritis painpain reliefpatient populationpre-clinicalprescription opioidprogramsrepairedresponseservice membersocioeconomicssubchondral bonetreatment response
项目摘要
Osteoarthritis (OA) is highly prevalent in U.S. military service members and Veterans due to the impact of
joint trauma and overuse injury. Its socioeconomic impact is substantial, estimated to approach $60 billion
per year, and no disease-modifying treatments exist. Collaborative programs (such as CaRe-AP) have been
proposed to develop a treatment for post-traumatic osteoarthritis (PTOA) that will relieve pain and improve
function. The hypothesis that PTOA is caused by maladaptive repair responses including activation of the
pro-inflammatory pathways of innate immunity that in turn result in pain, loss of function and structural
decline have been broadly accepted. To this end, OA has long been characterized as a ‘wear and tear’
disease but is now considered a cell-mediated condition involving low-grade innate inflammation affecting
all tissues of the joint (cartilage, bone, synovium, fat pads). Inflammatory processes increase the risk of
knee OA (kOA) onset and progression, though the role of inflammation in the kOA, and as a determinant in
successful treatments is unclear. Further, correlation of structural changes that result in progression of
degeneration in kOA with those that serve as pain generators in this disease is crucial. Opioid prescriptions
due to acute and chronic musculoskeletal pain visits increased by 50% between 2006 and 2010.
MRI of kOA has historically focused on tissue specific drivers of OA, most notably cartilage evaluation. Our
past work has pioneered a whole-joint approach to kOA, taking into consideration interactions between
cartilage, meniscus and subchondral bone. The current MRI literature on the synovium, synovial fluid,
infrapatellar fat pad (IFP) and bone marrow are limited, presenting a significant gap in MRI evaluation of
kOA. The overwhelming majority of MRI literature addressing synovitis/effusion involves intravenous
contrast-based protocols. In a patient population prone to peripheral vascular disease (affecting contrast
delivery) and requiring longitudinal follow-up, contrast administration is suboptimal. Given the histologic
elements of the inflammatory pathway in synovium, IFP and bone marrow, non-invasive identification and
characterization of cellular infiltrates as well as their distinction from synovial hyperplasia, fibrosis and
vascularity in tissues would represent a revolutionary step in understanding the role of inflammation in OA
progression and response to therapy. Restriction Spectrum Imaging (RSI) is a novel diffusion-weighted
technique that has been used to distinguish restricted diffusion within cells from other water compartments,
has higher resolution than standard diffusion sequences, and has the potential to be standardized across
institutions. Ultrashort Echo Time Dual Echo Steady State (UTE-DESS) combines UTE and DESS to
characterize tissues with a range of intrinsic MR properties and allows quantitative evaluation of those
properties (T1 and T2) as well as diffusion data. We hypothesize that these techniques can be used to
identify cellular infiltrates (RSI) and distinguish them from regions of fibrosis and vascularity (UTE-DESS) in
synovium, IFP and bone marrow in the setting of kOA.
The overall goal of this project is to optimize and validate novel non-invasive (RSI and UTE-DESS) MRI
biomarkers of joint inflammation that can identify and characterize inflammatory changes of cellular infiltrates,
fibrosis and vascularity in synovium, IFP and bone marrow. We will deploy these MR biomarkers of
inflammation in a preclinical animal model (mild, moderate and severe kOA) and translate optimized
sequences to assess conservative therapy in kOA subjects. We will develop a multi-variate statistical model
that incorporates outcomes from clinical morphologic MRI, novel optimized MR biomarkers of inflammation,
MR spectroscopy to create a structural/ biochemical framework to correlate with kOA pain/function.
骨关节炎(OA)在美国军人和退伍军人中非常普遍,这是由于以下因素的影响:
关节创伤和过度使用损伤。其社会经济影响巨大,估计接近600亿美元
每年,没有疾病修饰治疗存在。合作项目(如Care-AP)已经
建议开发一种治疗创伤后骨关节炎(PTOA)的方法,
功能PTOA是由适应不良的修复反应引起的假说,
先天免疫的促炎途径,这反过来又导致疼痛,功能和结构的丧失,
下降被广泛接受。为此,OA一直被定性为'磨损'
疾病,但现在被认为是一种细胞介导的条件,涉及低度先天性炎症,
关节的所有组织(软骨、骨、滑膜、脂肪垫)。炎症过程会增加
膝关节OA(kOA)的发病和进展,虽然炎症在kOA中的作用,并作为一个决定因素,
成功的治疗方法尚不清楚。此外,导致疾病进展的结构变化的相关性
在kOA与那些在这种疾病中作为疼痛发生器的退化是至关重要的。阿片类药物处方
2006年至2010年,因急性和慢性肌肉骨骼疼痛就诊的人数增加了50%。
kOA的MRI历来专注于OA的组织特异性驱动因素,最值得注意的是软骨评价。我们
过去的工作已经开创了一种整体联合的方法来解决kOA问题,考虑了
软骨、半月板和软骨下骨。目前关于滑膜,滑液,
髌下脂肪垫(IFP)和骨髓是有限的,在MRI评估中存在显著差距,
kOA。绝大多数关于滑膜炎/积液的MRI文献涉及静脉内
基于对比度的协议。在易患外周血管疾病(影响造影剂)的患者人群中
递送)并且需要纵向随访,造影剂施用是次优的。鉴于组织学
滑膜、IFP和骨髓中炎症途径的要素,非侵入性鉴定,
细胞浸润的表征以及它们与滑膜增生、纤维化和
组织中的血管分布将代表理解炎症在OA中的作用的革命性步骤
进展和治疗反应。限制谱成像(RSI)是一种新型的弥散加权成像技术,
已经用于区分细胞内的受限扩散与其他水隔室的技术,
具有比标准扩散序列更高的分辨率,并且有可能被标准化,
机构职能体系超短回波时间双回波稳态(UTE-DESS)结合了UTE和DESS,
表征具有一系列固有MR特性的组织,并允许对这些组织进行定量评价。
特性(T1和T2)以及扩散数据。我们假设这些技术可以用来
识别细胞浸润(RSI)并将其与纤维化和血管化区域(UTE-DESS)区分开来,
滑膜、IFP和骨髓。
本项目的总体目标是优化和验证新型无创(RSI和UTE-DESS)MRI
关节炎症的生物标志物,其可以识别和表征细胞浸润的炎性变化,
滑膜、IFP和骨髓中的纤维化和血管化。我们将部署这些MR生物标志物,
在临床前动物模型(轻度、中度和重度kOA)中观察炎症并优化翻译
序列,以评估kOA受试者的保守治疗。我们将建立一个多变量统计模型
它结合了临床形态MRI的结果,新的优化的炎症MR生物标志物,
磁共振波谱,以创建与kOA疼痛/功能相关的结构/生化框架。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTINE B CHUNG其他文献
CHRISTINE B CHUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTINE B CHUNG', 18)}}的其他基金
Development and Translation of Novel UTE-MuSIC MR Sequence to Image Around Metal
新型 UTE-MuSIC MR 序列的开发和转化为金属周围的图像
- 批准号:
8594503 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Development and Translation of Novel UTE-MuSIC MR Sequence to Image Around Metal
新型 UTE-MuSIC MR 序列的开发和转化为金属周围的图像
- 批准号:
9188779 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Ultrashort TE MR Imaging of Femorotibial Cartilage
股胫软骨超短 TE MR 成像
- 批准号:
10038791 - 财政年份:2012
- 资助金额:
-- - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant